Correlation Between Akari Therapeutics and Solitron Devices

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Solitron Devices at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Solitron Devices into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Solitron Devices, you can compare the effects of market volatilities on Akari Therapeutics and Solitron Devices and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Solitron Devices. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Solitron Devices.

Diversification Opportunities for Akari Therapeutics and Solitron Devices

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Akari and Solitron is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Solitron Devices in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solitron Devices and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Solitron Devices. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solitron Devices has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Solitron Devices go up and down completely randomly.

Pair Corralation between Akari Therapeutics and Solitron Devices

Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Solitron Devices. In addition to that, Akari Therapeutics is 2.97 times more volatile than Solitron Devices. It trades about -0.08 of its total potential returns per unit of risk. Solitron Devices is currently generating about 0.02 per unit of volatility. If you would invest  1,556  in Solitron Devices on November 2, 2024 and sell it today you would earn a total of  24.00  from holding Solitron Devices or generate 1.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Akari Therapeutics PLC  vs.  Solitron Devices

 Performance 
       Timeline  
Akari Therapeutics PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akari Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Solitron Devices 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Solitron Devices are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong fundamental indicators, Solitron Devices is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Akari Therapeutics and Solitron Devices Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akari Therapeutics and Solitron Devices

The main advantage of trading using opposite Akari Therapeutics and Solitron Devices positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Solitron Devices can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solitron Devices will offset losses from the drop in Solitron Devices' long position.
The idea behind Akari Therapeutics PLC and Solitron Devices pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements